Kiniksa Pharmaceuticals International, plc (KNSA) › Operating Cash FlowKiniksa Pharmaceuticals International, plc (KNSA) — Operating Cash FlowAnnual figures by period end, from SEC filings.2017-12-31: -$50.22M2018-12-31: -$81.01M2019-12-31: -$158.37M2020-12-31: -$136.53M2021-12-31: -$126.30M2022-12-31: $5.81M2023-12-31: $13.30M2024-12-31: $25.69M2025-12-31: $137.99M$137.99M2017-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31$137.99M+437.1%2026-02-24From 2025-01-012024-12-31$25.69M+93.1%2026-02-24From 2024-01-012023-12-31$13.30M+129.1%2026-02-24From 2023-01-012022-12-31$5.81M—2025-02-25From 2022-01-012021-12-31-$126.30M—2024-02-28From 2021-01-012020-12-31-$136.53M—2023-03-02From 2020-01-012019-12-31-$158.37M—2022-02-24From 2019-01-012018-12-31-$81.01M—2021-02-25From 2018-01-012017-12-31-$50.22M—2019-03-12From 2017-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)